Navigation Links
Ferring Pharmaceuticals Provides Baby Quest Foundation Grant Recipients with Free Access to Fertility Medication

PARSIPPANY, N.J., Aug. 20, 2013 /PRNewswire-USNewswire/ -- In a continued effort to support patients facing infertility, Ferring Pharmaceuticals Inc. today announced a donation to Baby Quest Foundation, Inc. – a non-profit organization focused on providing financial assistance to patients pursuing fertility treatment. Through this collaboration, Ferring will provide 10 Baby Quest grant recipients with free access to select fertility medications, enabling them to undergo one full IVF cycle, with the hopes of helping them achieve their dream of parenthood.


It is estimated that about 6.7 million women between the ages of 15 to 44 in the U.S. experience infertility or the inability to carry a baby to term. [i]

"Each year, millions of families struggle with getting pregnant," said Justin Rauschkolb, Manager of Product Promotions of Ferring's reproductive health unit.  "Through our work with Baby Quest, we aspire to help some of these patients build and grow their families, while also providing hope for others still on the journey to becoming parents."

Ferring and Baby Quest kicked off their partnership at NASDAQ, where Baby Quest co-founder Pamela Hirsch and team rang the opening bell.  

"We are so thankful for the generosity of Ferring Pharmaceuticals in donating medication so that our grant recipients can pursue infertility treatment," said Hirsch.  "Their donation allows us to continue our work of increasing public awareness of the condition of infertility and of providing financial assistance to those who cannot afford the high costs of fertility treatments."

Ferring, as a company, has a commitment to helping patients realize their dream of parenthood. In addition to their work with Baby Quest, Ferring has other initiatives supporting both patients facing infertility and the community including:

  • Heart Beat Patient Assistance Program – Offers financial assistance for eligible patients pursuing fertility preservation services prior to cancer treatment. For more information, visit
  • 2013 Heart to Heart Video Contest – Allows participants the chance to win up to $15,000 toward their child's education for submitting a video essay telling the story of their steps on the path to parenthood. For more information or to submit a video by the August 31st deadline, visit
  • Local Playground Adoption – The Reproductive Health Unit of Ferring's Parsippany office adopted a local playground as a part of the Morristown "Adopt-a-Spot" program and Ferring's "Living the Philosophy" initiative, which grants employees one day per quarter to dedicate to service. Ferring will be responsible for upkeep of the park throughout the year. For more information about Ferring's community involvement, visit

To learn more about Ferring's initiatives in reproductive health, visit

About Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urologygastroenterologyendocrinology and osteoarthritis. For more information, visit

[i]"Infertility." Centers for Disease Control and Prevention. 2013.

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals Inc. Announces $1M Donation to the Alliance for Fertility Preservation, a Newly Formed Charitable Organization
2. Ferring Pharmaceuticals Extends Its Heart to Heart Video Contest
3. Ferring Pharmaceuticals Inc. Adopts Local Morristown Playground
4. Ferring Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologists Annual Clinical Meeting
5. Ferring to Highlight Phase 3 Data for Cervical Ripening Candidate at Society for Maternal-Fetal Medicine Annual Meeting
6. Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
7. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
8. ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)
9. Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.
10. HedgePath Pharmaceuticals, Inc. Completes Reorganization Plan with Commonwealth Biotechnologies
11. TetraLogic Pharmaceuticals Announces New Executives
Post Your Comments:
(Date:12/1/2015)... Sensor Networks, a leader in intelligent sensors and analytic software for sensor network-based systems, announced ... data collection of vital signs. Photo - ... ... ... ...
(Date:12/1/2015)... , Dec. 1, 2015 Ampio Pharmaceuticals, ... York Stock Exchange has established January 5, 2016 as the ... stockholders of the shares of Common Stock of Aytu ... share of Aytu common stock for every five (5) ... record date, December 1, 2015. The distribution date will be ...
(Date:12/1/2015)... Sweden , December 1, 2015 ... International Breast Cancer Study Group (IBCSG, Bern ... ) to be part of a state of the ... cancer drug.  --> --> ... cancer being treated with anti-hormonal therapy in combination with palbociclib, ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... Next IT Healthcare, the leader in patient ... year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher of ... the category of Digital Solutions for its innovative, industry-leading product, Alme Health Coach. ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Lutronic, a ... of Clarity, the latest addition to the devices for sale in the United States. ... nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... SACC-GA and SACC-USA through membership and leadership since 2008. Gary Bruce, President ... SACC-USA . Gary has spent a significant amount of time in Sweden ...
(Date:12/1/2015)... ... December 01, 2015 , ... Nurotron Biotechnology Co., Ltd., ... largest order to date. , The order will be from the China Disabled ... Cochlear Implant System is an effective solution for children and adults suffering from ...
Breaking Medicine News(10 mins):